Trastuzumab and diarrhoea Patient Reports February 11, 2012
Trastuzumab Side Effects Report #5525504-X
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 12, 2007. Male patient, weighting 96.98 lb, was diagnosed with gastric cancer and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: abdominal pain
, diarrhoea, oesophageal candidiasis, pneumonia
. Trastuzumab dosage: 8 MG/KG, Q3W. During the same period patient was treated with CAPECITABINE, CISPLATIN, OXYCONTIN, FURIX, ADALAT, MOSAPRIDE CITRATE. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5296028-2
Trastuzumab side effect was reported by a Health Professional from GREECE on Mar 21, 2007. Female patient, 72 years of age, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: blood bilirubin increased, breast cancer metastatic, diarrhoea, ejection fraction decreased, liver disorder, malignant neoplasm progression. Trastuzumab dosage: 2 MG/KG, UNK, INTRAVENOUS. During the same period patient was treated with LAPATINIB. Patient died on 01/19/2007.
Trastuzumab Side Effects Report #4918553-3
Trastuzumab side effect was reported by a Physician from UNITED STATES on Feb 21, 2006. Female patient, 53 years of age, weighting 167.0 lb, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, fall
, gastroenteritis viral, influenza, sinusitis
. Trastuzumab dosage: 137.2MG QWK IV. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5115303-5
Trastuzumab side effect was reported by a Physician from AUSTRALIA on Mar 14, 2006. Female patient, 50 years of age, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: catheter related complication, chest pain
, diarrhoea, dyspnoea, pyrexia, staphylococcal infection
. Trastuzumab dosage: 2 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with NAVELBINE, CAPECITABINE, TRAMADOL, ESOMEPRAZOLE. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5128130-X
Trastuzumab side effect was reported by a Pharmacist from AUSTRALIA on Sept 21, 2006. Female patient, 50 years of age, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: catheter related complication, central line infection, chest pain
, diarrhoea, dyspnoea, haemoglobin decreased, staphylococcal infection
, thrombosis, white blood cell count decreased. Trastuzumab dosage: 2 MG/KG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with NAVELBINE, CAPECITABINE, TRAMADOL, ESOMEPRAZOLE, MAXOLON. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5291224-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Apr 08, 2007. Female patient, weighting 99.21 lb, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: diarrhoea, haematocrit decreased, haemoglobin decreased, monocyte percentage decreased, neutrophil percentage increased, white blood cell count increased. Trastuzumab dosage: 85.4 MG, 1/WEEK. During the same period patient was treated with PACLITAXEL, MYOCET. Patient died on 02/04/2007.
Trastuzumab Side Effects Report #5372671-7
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on June 14, 2007. Female patient, weighting 99.21 lb, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: diarrhoea. Trastuzumab dosage: 85.4 MG, 1/WEEK. During the same period patient was treated with PACLITAXEL, MYOCET. Patient died on 02/04/2007.
Trastuzumab Side Effects Report #5385368-4
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on June 29, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: diarrhoea. Trastuzumab dosage: 4 MG/KG, SINGLE. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient died on 06/14/2007.
Trastuzumab Side Effects Report #5465960-9
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on June 20, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea. Trastuzumab dosage: 4 MG/KG, UNK. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient died on 06/14/2007.
Trastuzumab Side Effects Report #5565133-5
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Dec 05, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, infection
. Trastuzumab dosage: 4 MG/KG, 1/WEEK. During the same period patient was treated with PACLITAXEL, LAPATINIB, ALPRAZOLAM, VALSARTAN, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5603081-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Jan 11, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, infection
. Trastuzumab dosage: 4 MG/KG, 1/WEEK. During the same period patient was treated with PACLITAXEL, LAPATINIB, ALPRAZOLAM, VALSARTAN, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #4892400-0
Trastuzumab side effect was reported by a Physician from UNITED STATES on Jan 23, 2006. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, fall
, influenza, nausea
. Trastuzumab dosage: 2 MG/KG QWK IV. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #6056077-3
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Jan 13, 2009. Female patient was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, pain
, rash maculo-papular, stomatitis. Trastuzumab dosage: 8 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, FERROUS SULPHATE, PROMETHAZINE, PRILOSEC. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #6068775-6
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2009. Female patient was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: asthenia, blood calcium decreased, blood glucose increased, blood potassium decreased, blood sodium decreased, dehydration, diarrhoea, febrile neutropenia, ileus. Trastuzumab dosage: 8 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, FERROUS SULPHATE, PROMETHAZINE, PRILOSEC. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #6130314-9
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Mar 09, 2009. Female patient was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, pain
, rash maculo-papular, stomatitis. Trastuzumab dosage: 8 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, FERROUS SULPHATE, PROMETHAZINE. Patient was hospitalized. Patient recovered.
Trastuzumab and diarrhoea 